Abstract:Transplantation of dopaminergic precursors (DPs) is a promising therapeutic strategy of Parkinson's disease (PD). However, limited cell source for dopaminergic precursors has become a major obstacle for transplantation therapy. Our group demonstrated previously that mouse fibroblasts can be reprogrammed into induced dopaminergic precursors (iDPs) with high differentiation efficiency. In the current study, we hypothesized that a similar strategy can be applied to generate human iDPs for future cell therapy of PD. We overexpressed transcription factors Brn2, Sox2, and Foxa2 in human fibroblasts and observed formation of neurospheres. Subsequent characterization of the precursor colonies confirmed the generation of human induced dopaminergic precursors (hiDPs). These hiDPs were capable of self-renewal, proliferation, and differentiation. The hiDPs demonstrated high immunoreactivity for neural progenitor markers and high levels of gene expression for ventral mesencephalon-related neural progenitor markers such as Lmx1a, NIKX6.1, Corin, Otx2 and Mash1. Furthermore, the hiDPs could be differentiated into dopaminergic neurons with ˜80% efficiency, which significantly increased major functionally relevant proteins such as TH, DAT, AADC, Lmx1B, and VMAT2 compared to hiDPs. Additionally, hiDPs are more dopaminergic progenitor-restricted compare to those hiDP-like cells reprogrammed only by Brn2 and Sox2. Together, these results suggest that hiDPs with high differentiation efficiency can be generated by direct lineage reprogramming of fibroblasts with transcription factors Brn2, Sox2, and Foxa2. These hiDPs may serve as a safe and effective cell source for transplantation treatment of PD.

Conversion of Fibroblasts to Neural Cells by P53 Depletion

RESULTS Knockout of p 53 Converts Fibroblasts into Neurons , Astrocytes , and Oligodendrocytes

Cell Cycle and P53 Gate the Direct Conversion of Human Fibroblasts to Dopaminergic Neurons

Attenuation of PRRX2 and HEY2 Enables Efficient Conversion of Adult Human Skin Fibroblasts to Neurons.

Retraction Note: Senescence Impairs Direct Conversion of Human Somatic Cells to Neurons

Direct Conversion of Dermal Fibroblasts into Neural Progenitor Cells by a Novel Cocktail of Defined Factors.

Direct Conversion of Fibroblasts to Neurons by Reprogramming PTB-Regulated MicroRNA Circuits

Selective Generation of Dopaminergic Precursors from Human Fibroblasts by Direct Lineage Conversion

Pharmacological Reprogramming of Fibroblasts into Neural Stem Cells by Signaling-Directed Transcriptional Activation

Direct Reprogramming of Mouse Fibroblasts to Neural Progenitors

Increase Developmental Plasticity Of Human Keratinocytes With Gene Suppression

Neuronal Transcription Factors Induce Conversion of Human Glioma Cells to Neurons and Inhibit Tumorigenesis

How to Reprogram Human Fibroblasts to Neurons

P53 Transcription-Dependent and -Independent Regulation of Cerebellar Neural Precursor Cell Apoptosis

Direct Conversion of Normal and Alzheimer’s Disease Human Fibroblasts into Neuronal Cells by Small Molecules

Direct Reprogramming of Adult Human Fibroblasts to Functional Neurons under Defined Conditions.

Direct Reprogramming of Fibroblasts into Neural Stem Cells by Single Non-Neural Progenitor Transcription Factor Ptf1a

Small Molecular Compounds Efficiently Convert Human Fibroblasts Directly into Neurons

Deacetylation of p53 after nerve growth factor treatment in PC12 cells as a post-translational modification mechanism of neurotrophin-induced tumor suppressor activation

Direct Conversion of Mouse Fibroblasts into Neural Stem Cells by Chemical Cocktail Requires Stepwise Activation of Growth Factors and Nup210

Hierarchical Mechanisms for Direct Reprogramming of Fibroblasts to Neurons.